REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Novascon Pharmaceuticals Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Other Miscellaneous Manufacturing | Merchant Wholesalers, Durable Goods | Information | Motion Picture and Sound Recording Industries | Scientific Research and Development Services | All Other Professional, Scientific, and Technical Services | Office Administrative Services | Other Personal Care Services
Full name: Novascon Pharmaceuticals Sp. z o.o. Profile Updated: April 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Novascon Pharmaceuticals Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. The enterprise operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. The enterprise was incorporated on May 28, 2007. It currently has a total number of 55 (2020) employees. The latest financial highlights indicate a net sales revenue increase of 36.88% in 2022. There was a total negative growth of 84.98% in Novascon Pharmaceuticals Sp. z o.o.’s total assets over the same period. The net profit margin of Novascon Pharmaceuticals Sp. z o.o. increased by 43.21% in 2022.

Headquarters
Ul. Skierniewicka 10A
Warsaw; Mazowieckie; Postal Code: 01-230

Contact Details: Purchase the Novascon Pharmaceuticals Sp. z o.o. report to view the information.

Website: http://www.novascon.pl

Basic Information
Total Employees:
Purchase the Novascon Pharmaceuticals Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Novascon Pharmaceuticals Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Novascon Pharmaceuticals Sp. z o.o. report to view the information.
Incorporation Date:
May 28, 2007
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Inpharmax Investments Sp. z o.o.
45.05%
Inpharmax Investments Sp. z o.o. sp. j.
Company Performance
Financial values in the chart are available after Novascon Pharmaceuticals Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
36.88%▲
Total operating revenue
45.55%▲
Operating profit (EBIT)
72.43%▲
EBITDA
72.93%▲
Net Profit (Loss) for the Period
60.43%▲
Total assets
-84.98%▼
Total equity
N/A
Operating Profit Margin (ROS)
53.29%▲
Net Profit Margin
43.21%▲
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
0.05%▲
Cash Ratio
-0.06%▼

Similar companies

Mos Consulting Sp. z o.o.
 
Unilever Polska Sp. z o.o.
Bausch Health Poland Sp. z o.o.
 
Mgi Polska Sp. z o.o.
W.Eg Polska Sp. z o.o.
 
Doz S.A. Direct sp. k.
Arina Sp. z o.o.
 
Sped Malaga Edward, Malaga Renata sp. j.
Agro-Jumal Sp. z o.o.
 
Mpsystem Sp. z o.o.
Handlog Sp. z o.o. sp. j.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo